Abstract:Abstract Background Cancer metastasis is a complex process involving the spread of malignant cells from a primary tumor to distal organs. Understanding this cascade at a mechanistic level could provide critical new insights into the disease and potentially reveal new avenues for treatment. Transcriptome profiling of spontaneous cancer models is an attractive method to examine the dynamic changes accompanying tumor cell spread. However, such studies are complicated by the underlying heterogeneity of the cell types involved. The purpose of this study was to examine the transcriptomes of metastatic breast cancer cells using the well-established MMTV-PyMT mouse model. Methods Organ-derived metastatic cell lines were harvested from 10 female MMTV-PyMT mice. Cancer cells were isolated and sorted based on the expression of CD44 low /EpCAM high or CD44 high /EpCAM high surface markers. RNA from each cell line was extracted and sequenced using the NextSeq 500 Illumina platform. Tissue-specific genes were compared across the different metastatic and primary tumor samples. Reads were mapped to the mouse genome using STAR, and gene expression was quantified using RSEM. Single-cell RNA-seq (scRNA-seq) was performed on select samples using the ddSeq platform by BioRad and analyzed using Seurat v3.2.3. Monocle2 was used to infer pseudo-time progression. Results Comparison of RNA sequencing data across all cell populations produced distinct gene clusters. Differential gene expression patterns related to CD44 expression, organ tropism, and immunomodulatory signatures were observed. scRNA-seq identified expression profiles based on tissue-dependent niches and clonal heterogeneity. These cohorts of data were narrowed down to identify subsets of genes with high expression and known metastatic propensity. Dot plot analyses further revealed clusters expressing cancer stem cell and cancer dormancy markers. Changes in relevant genes were investigated across pseudo-time and tissue origin using Monocle2. These data revealed transcriptomes that may contribute to sub-clonal evolution and treatment evasion during cancer progression. Conclusions We performed a comprehensive transcriptome analysis of tumor heterogeneity and organ tropism during breast cancer metastasis. These data add to our understanding of metastatic progression and highlight targets for breast cancer treatment. These markers could also be used to image the impact of tumor heterogeneity on metastases.

A tale of mice and (wo)men: development of and insights from an "all human" animal model of breast cancer metastasis to bone

Modeling Spontaneous Bone Metastasis Formation of Solid Human Tumor Xenografts in Mice

Bone metastasis in a novel breast cancer mouse model containing human breast and human bone

Immune system augmentation via humanization using stem/progenitor cells and bioengineering in a breast cancer model study

An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche

Establishment and characterization of a C57BL/6 mouse model of bone metastasis of breast cancer

Models of breast cancer: quo vadis, animal modeling?

Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2 breast cancer

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Canine as a Comparative and Translational Model for Human Mammary Tumor

Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy

A humanised rat model of osteosarcoma reveals ultrastructural differences between bone and mineralised tumour tissue

Trials, Tribulations, and Trends in Tumor Modeling in Mice

Orthotopic and metastatic tumour models in preclinical cancer research

Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer

Primary Bone Tumors and Breast Cancer-Induced Bone Metastases: In Vivo Animal Models and New Alternative Approaches

Abstract IA012: Modeling prostate cancer metastasis in genetically engineered mouse models

Abstract A062: Somatic engineering of rat models to recapitulate human breast cancer evolution and heterogeneity

Transcriptome analysis of heterogeneity in mouse model of metastatic breast cancer

Animal models of cancer metastasis to the bone

“Isolation and characterization of a novel hormone receptor positive mammary adenocarcinoma MCa-P1362 with stromal drivers of tumor growth, metastasis, and drug resistance”